GIPR
Gastric inhibitory polypeptide receptor
Also known as: GIPR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48546
- Gene
- GIPR
- Ensembl
- ENSG00000010310
- Chromosome
- 19
- Canonical length
- 466 aa
- Protein class
- G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a G-protein coupled receptor for gastric inhibitory polypeptide (GIP), which was originally identified as an activity in gut extracts that inhibited gastric acid secretion and gastrin release, but subsequently was demonstrated to stimulate insulin release in the presence of elevated glucose. Mice lacking this gene exhibit higher blood glucose levels with impaired initial insulin response after oral glucose load. Defect in this gene thus may contribute to the pathogenesis of diabetes. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
466 residues, UniProt reviewed canonical sequence.
>P48546|GIPR
1 MTTSPILQLL LRLSLCGLLL QRAETGSKGQ TAGELYQRWE RYRRECQETL AAAEPPSGLA
61 CNGSFDMYVC WDYAAPNATA RASCPWYLPW HHHVAAGFVL RQCGSDGQWG LWRDHTQCEN
121 PEKNEAFLDQ RLILERLQVM YTVGYSLSLA TLLLALLILS LFRRLHCTRN YIHINLFTSF
181 MLRAAAILSR DRLLPRPGPY LGDQALALWN QALAACRTAQ IVTQYCVGAN YTWLLVEGVY
241 LHSLLVLVGG SEEGHFRYYL LLGWGAPALF VIPWVIVRYL YENTQCWERN EVKAIWWIIR
301 TPILMTILIN FLIFIRILGI LLSKLRTRQM RCRDYRLRLA RSTLTLVPLL GVHEVVFAPV
361 TEEQARGALR FAKLGFEIFL SSFQGFLVSV LYCFINKEVQ SEIRRGWHHC RLRRSLGEEQ
421 RQLPERAFRA LPSGSGPGEV PTSRGLSSGT LPGPGNEASR ELESYCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GIPR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- stomach: 21 nTPM
- heart muscle: 14 nTPM
- retina: 12 nTPM
- pancreas: 10 nTPM
- adipose tissue: 9.3 nTPM
- breast: 8.8 nTPM
Single-cell type
- respiratory ciliated cells: 120 nCPM
- foveolar cells: 95 nCPM
- neuroendocrine cells: 82 nCPM
- pancreatic islet cells: 54 nCPM
- colonocytes: 50 nCPM
- fallopian tube ciliated cells: 41 nCPM
Immune cell
- basophil: 1.2 nTPM
- NK-cell: 1.1 nTPM
- eosinophil: 0.5 nTPM
- gdT-cell: 0.5 nTPM
- neutrophil: 0.5 nTPM
- naive B-cell: 0.4 nTPM
Brain region
- midbrain: 12 nTPM
- pons: 11 nTPM
- white matter: 11 nTPM
- thalamus: 11 nTPM
- cerebral cortex: 8.8 nTPM
- medulla oblongata: 8.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.96
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of adenylate cyclase activity
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- adenylate cyclase-modulating G protein-coupled receptor signaling pathway
- cell surface receptor signaling pathway
- desensitization of G protein-coupled receptor signaling pathway
- endocrine pancreas development
- gastric inhibitory peptide signaling pathway
- generation of precursor metabolites and energy
- positive regulation of cytosolic calcium ion concentration
- positive regulation of insulin secretion
- regulation of insulin secretion
- response to axon injury
- response to calcium ion
- response to fatty acid
- response to glucose
- response to nutrient
Molecular functions
- G protein-coupled peptide receptor activity
- peptide hormone binding
- transmembrane signaling receptor activity
- gastric inhibitory peptide receptor activity
- glucagon family peptide binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPCR, family 2, secretin-like
- GPCR, family 2, extracellular hormone receptor domain
- GPCR, family 2-like, 7TM
- GPCR, family 2, secretin-like, conserved site
- GPCR family 2, extracellular hormone receptor domain superfamily
- G-protein coupled receptor 2
- 7 transmembrane receptor (Secretin family)
- Hormone receptor domain
- GPCR, family 2, gastric inhibitory polypeptide receptor
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GIPR as an antibody target. Whether an autoantibody or antibody against GIPR could matter depends on whether native GIPR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GIPR is annotated at the cell surface, where native GIPR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GIPR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...